Related Experiment Videos
[Saliva phenobarbital concentration in epileptics]
Zhonghua Shen Jing Jing Shen Ke Za Zhi = Chinese Journal of Neurology and Psychiatry
|December 1, 1989
Summary
Saliva phenobarbital levels closely mirror serum concentrations in epilepsy patients. This finding supports using non-invasive saliva tests for effective phenobarbital monitoring in epilepsy management.
Area of Science:
- Pharmacology
- Clinical Chemistry
- Neurology
Background:
- Therapeutic drug monitoring (TDM) is crucial for optimizing epilepsy treatment.
- Serum phenobarbital levels are commonly used for TDM, but invasive blood collection can be challenging.
- Saliva offers a non-invasive alternative for drug concentration measurement.
Purpose of the Study:
- To investigate the correlation between phenobarbital concentrations in saliva and serum.
- To evaluate the utility of saliva phenobarbital measurements for therapeutic drug monitoring in epileptic patients.
Main Methods:
- Simultaneous collection of saliva and serum samples from 33 epileptic patients.
- Quantification of phenobarbital concentrations using Radioimmunoassay (RIA).
- Statistical analysis to determine the correlation between saliva and serum levels.
Main Results:
- Mean phenobarbital concentration in saliva was 3.2 ± 1.78 µg/ml and in serum was 11.75 ± 7.4 µg/ml.
- The mean saliva-to-serum ratio for phenobarbital was 0.27 ± 0.08.
- A strong positive correlation (R = 0.7922, P < 0.01) was observed between saliva and serum phenobarbital concentrations.
Conclusions:
- Saliva phenobarbital concentrations are closely correlated with total serum levels in epileptic patients.
- Saliva testing is a viable, non-invasive method for monitoring phenobarbital therapy in epilepsy.
- The ease and convenience of saliva collection enhance patient compliance and facilitate efficient TDM.